Please assess the completion status of the following clinical trial:

Trial Title: Remote Ischemic Preconditioning in Coronary Artery Bypass Grafting With Cold Crystalloid Cardioplegic Arrest

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Consecutive patients \>18 years of age~* Double- or triple-vessel coronary artery disease~* Elective isolated first-time CABG~* Combined valve surgery + CABG~* Written informed consent~Exclusion Criteria:~* Renal failure (creatinine ≥ 200 µmol/L)~* Peripheral vascular disease affecting upper limbs~* Preoperative inotropic support~* Any kind of mechanical assist device~* Acute or recent (\<4 weeks) acute coronary syndromes~* Any PCI (\<6 weeks)~* Any reasons for preoperative cTnI elevation~* Emergency surgery~* Redo surgery

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- RIPC (Type: ACTIVE_COMPARATOR): Remote ischemic preconditioning (RIPC) protocol before coronary artery bypass surgery consists of 3 cycles of 5 minutes left upper arm ischemia by inflation of a blood pressure cuff to 200 mmHg and 5 minutes of reperfusion after induction of anesthesia before coronary artery bypass surgery. For myocardial molecular analyses, left ventricular biopsies are taken before induction of cardioplegic cardiac arrest and 5 and 10 Minutes after aortic unclamping during reperfusion of the myocardium.
- Control (Type: PLACEBO_COMPARATOR): Control group: Coronary artery bypass surgery without remote ischemic preconditioning protocol

Based on this trial design, predict the completion outcome and termination type (if applicable).